Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Circulating IL-6 and survival outcomes in renal cell carcinoma: a systematic review and meta-analysis

Haryo Nindito Wicaksono, Taufiq Nur Budaya, Kurnia Penta Seputra, Aulia Rahman Putra

30-09-2025

https://doi.org/10.4081/aiua.2025.13955

517

Downloads: 587
Prognostic significance of pretreatment hydronephrosis in radiotherapy-based bladder-preserving strategies for muscle-invasive bladder cancer: a systematic review and meta-analysis

Rizki Fauzan Ghali Nasution, Syah Mirsya Warli, Fauriski Febrian Prapiska

29-05-2026

https://doi.org/10.4081/aiua.2026.14945

127

Downloads: 113
Surveillance as a safe and effective option for treatment of stage I seminoma

Vasco Quaresma, Diogo Henriques, Lorenzo Marconi, João Lorigo, Ana-Marta Ferreira, Roberto Jarimba, Pedro Nunes, Arnaldo Figueiredo, Belmiro Parada

05-09-2023

https://doi.org/10.4081/aiua.2023.11513

850

Downloads: 488
A systematic review and meta-analysis of intraarterial chemotherapy for non muscle invasive bladder cancer: Promising alternative therapy in high tuberculosis burden countries

Zakaria Aulia Rahman, Furqan Hidayatullah, Jasmine Lim, Lukman Hakim

16-02-2024

https://doi.org/10.4081/aiua.2024.12154

1739

Downloads: 3402
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis

Gianpaolo Perletti, Elena Monti, Emanuela Marras, Anne Cleves, Vittorio Magri, Alberto Trinchieri, Paul S. Rennie

121-129

07-07-2015

https://doi.org/10.4081/aiua.2015.2.121

11200

Downloads: 5992
Prostate-speciﬁc antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival

Alexandre Mendonça Macedo, Rita Gameiro Marques, Margarida Cunha André, Nuno Silva Figueira, Miguel Leal Carvalho

22-02-2023

https://doi.org/10.4081/aiua.2023.11052

1358

Downloads: 1068
The impact of tumor invasion to muscularis mucosaevascular plexus on patient outcome in pT1 bladder urothelial carcinoma

Ahmet Sahan, Fatma Gerin, Asgar Garayev, Emine Bozkurtlar, Alkan Çubuk, Orkunt Ozkaptan, Kasım Ertas, Yıloren Tanıdır, Haydar Kamil Cam, Ilker Tınay

02-10-2020

https://doi.org/10.4081/aiua.2020.3.239

1135

Downloads: 612
Prognostic impact of ReTURB in high grade T1 primary bladder cancer

Roberto Sanseverino, Giorgio Napodano, Antonio Campitelli, Maria Addesso

81-85

04-07-2016

https://doi.org/10.4081/aiua.2016.2.81

2440

Downloads: 1475
Stereotactic radiotherapy in oligometastatic prostate cancer: a single-center experience

Ana Marta Ferreira, José Miguel Cunha, Edgar Tavares da Silva, Pedro Nunes, Arnaldo Figueiredo

29-05-2026

https://doi.org/10.4081/aiua.2026.15530

152

Downloads: 92
Renal cell carcinoma in native kidneys before transplantation - When will we stop waiting?

Jorge Correia, Bernardo Teixeira, Gonçalo Mendes, Avelino Fraga, Miguel Silva-Ramos

15-03-2023

https://doi.org/10.4081/aiua.2023.11240

1151

Downloads: 728
Hyperthermic vs normothermic mitomycin C for intermediate-risk NMIBC: a real-world retrospective cohort study

José Alberto Pereira, Duarte Vieira-Brito, Ana Maria Ferreira, Rita Marques, Ana Patrícia Matos, Mário Lourenço, Ricardo Godinho, Pedro Peralta, Bruno Jorge Pereira, Paulo Jorge Conceição, Carlos Rabaça

05-11-2025

https://doi.org/10.4081/aiua.2025.14167

694

Downloads: 315
Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer

Lampros Mitrakas, Stavros Gravas, Foteini Karasavvidou, Ioannis Zachos, Anastasios Karatzas, Athanasios Oeconomou, Georgios Koukoulis, Vasilios Tzortzis, Christos Papandreou

143-147

28-06-2021

https://doi.org/10.4081/aiua.2021.2.143

1370

Downloads: 647
Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma

Kevin Yuwono, Junjungan Nimasratu Rahmatsani, Nadhifah Nadhifah, Revina Maharani, Zakaria Aulia Rahman

16-06-2025

https://doi.org/10.4081/aiua.2025.13880

897

Downloads: 697
Neoadjuvant chemotherapy versus cystectomy in management of stages II, and III urinary bladder cancer

Mohammed A. Osman, Ayman M. Gabr, Mohammad S. Elkady

278-283

30-12-2014

https://doi.org/10.4081/aiua.2014.4.278

2770

Downloads: 1404
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3)

Luca Bongiovanni, Vincenzo Arena, Fabio Maria Vecchio, Marco Racioppi, Pierfrancesco Bassi, Francesco Pierconti

73-77

24-06-2013

https://doi.org/10.4081/aiua.2013.2.73

2239

Downloads: 1862
Impact of statins on metastatic castration-resistant prostate cancer patients receiving new hormonal agents

Ana Marta Ferreira, Tiago Sousa, Roberto Jarimba, Vasco Quaresma, Pedro Nunes, Edgar Tavares da Silva, Arnaldo Figueiredo

03-11-2025

https://doi.org/10.4081/aiua.2025.14179

909

Downloads: 526
Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer

Ana Marta Ferreira, Roberto Jarimba, André Rego, João Gama, Rui Almeida, Miguel Eliseu, Vasco Quaresma, Pedro Nunes, Vitor Sousa, Arnaldo Figueiredo

31-03-2026

https://doi.org/10.4081/aiua.2026.14731

290

Downloads: 212
C reactive protein/Albumin ratio as predictor of prognosis in castration resistant metastatic prostate cancer

João Lorigo, Edgar Tavares Silva, João Pedroso Lima, Vasco Quaresma, Rui Pedrosa, Arnaldo Figueiredo

11-07-2023

https://doi.org/10.4081/aiua.2023.11242

1275

Downloads: 683
Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience

Nuno Dias, Lara Rodriguez-Sanchez, Gianmarco Colandrea, Petr Macek, Xavier Cathelineau

413-419

27-12-2022

https://doi.org/10.4081/aiua.2022.4.413

1128

Downloads: 745
Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer Network

Piero Bettoli, ZhihuiAmy Liu, Natalia Jara, Federico Bakal, William Wong, Mario Terlizzi, Paul Sargos, Thomas Zilli, Juliette Thariat, Sebastian Sole, Guilaume Ploussard, Sharad Goyal, Peter Chung, Alejandro Berlin, Claudio Sole

25-07-2023

https://doi.org/10.4081/aiua.2023.11533

1737

Downloads: 912

1 - 20 of 20 items

Search

Search Results

Circulating IL-6 and survival outcomes in renal cell carcinoma: a systematic review and meta-analysis

Prognostic significance of pretreatment hydronephrosis in radiotherapy-based bladder-preserving strategies for muscle-invasive bladder cancer: a systematic review and meta-analysis

Surveillance as a safe and effective option for treatment of stage I seminoma

A systematic review and meta-analysis of intraarterial chemotherapy for non muscle invasive bladder cancer: Promising alternative therapy in high tuberculosis burden countries

Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis

Prostate-speciﬁc antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival

The impact of tumor invasion to muscularis mucosaevascular plexus on patient outcome in pT1 bladder urothelial carcinoma

Prognostic impact of ReTURB in high grade T1 primary bladder cancer

Stereotactic radiotherapy in oligometastatic prostate cancer: a single-center experience

Renal cell carcinoma in native kidneys before transplantation - When will we stop waiting?

Hyperthermic vs normothermic mitomycin C for intermediate-risk NMIBC: a real-world retrospective cohort study

Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer

Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma

Neoadjuvant chemotherapy versus cystectomy in management of stages II, and III urinary bladder cancer

HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3)

Impact of statins on metastatic castration-resistant prostate cancer patients receiving new hormonal agents

Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer

C reactive protein/Albumin ratio as predictor of prognosis in castration resistant metastatic prostate cancer

Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience

Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer Network

authors

reviewers

indexing